You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

Cancer Care Ontario Beyond-Use Date Recommendations Report

Version: 1 ID: N/A mar 2018
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
Beyond-Use Date Mitigation Strategy Working Group

Guideline Objective

To address the drug waste issue related to Beyond-Use-Dates (BUD) implementation as per the NAPRA Model Standards, a BUD Mitigation Strategy Working Group was created. The primary objective of the Working Group was to develop a Recommendations Report which complies with the NAPRA Model Standards for BUD and provides potential strategies to minimize wastage due to single-dose vials.

Patient Population

N/A

Intended Guideline Users

Providers (Pharmacists and other Health Professionals)

Research Questions

N/A

pdf download Full Report (PDF) (242.27 Ko)